Ali Albenmousa

581 total citations
32 papers, 361 citations indexed

About

Ali Albenmousa is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Ali Albenmousa has authored 32 papers receiving a total of 361 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Hepatology, 19 papers in Epidemiology and 12 papers in Surgery. Recurrent topics in Ali Albenmousa's work include Liver Disease Diagnosis and Treatment (17 papers), Hepatitis C virus research (11 papers) and Hepatitis B Virus Studies (10 papers). Ali Albenmousa is often cited by papers focused on Liver Disease Diagnosis and Treatment (17 papers), Hepatitis C virus research (11 papers) and Hepatitis B Virus Studies (10 papers). Ali Albenmousa collaborates with scholars based in Saudi Arabia, United States and Egypt. Ali Albenmousa's co-authors include Faisal M. Sanai, Ayman A. Abdo, Khalid Alswat, Hamad I. Al‐Ashgar, Mohammed N. Al‐Ahdal, Ahmed A. Al‐Qahtani, Mohammed Q. Khan, Mashael R. Al‐Anazi, Khalid Bzeizi and Waleed K. Al‐Hamoudi and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Ali Albenmousa

28 papers receiving 355 citations

Peers

Ali Albenmousa
Ali Albenmousa
Citations per year, relative to Ali Albenmousa Ali Albenmousa (= 1×) peers Abdelrahman Kobtan

Countries citing papers authored by Ali Albenmousa

Since Specialization
Citations

This map shows the geographic impact of Ali Albenmousa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ali Albenmousa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ali Albenmousa more than expected).

Fields of papers citing papers by Ali Albenmousa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ali Albenmousa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ali Albenmousa. The network helps show where Ali Albenmousa may publish in the future.

Co-authorship network of co-authors of Ali Albenmousa

This figure shows the co-authorship network connecting the top 25 collaborators of Ali Albenmousa. A scholar is included among the top collaborators of Ali Albenmousa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ali Albenmousa. Ali Albenmousa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Al-Judaibi, Bandar, Hazzaa Alzahrani, Ali Alahmari, et al.. (2025). Emerging need for a hepato-hematology program for patients with sickle cell disease in Saudi Arabia. Saudi Journal of Gastroenterology. 31(2). 53–58.
3.
Alqahtani, Saleh A., Saad Alghamdi, Waleed Al-hamoudi, et al.. (2025). Assessment of ChatGPT-generated medical Arabic responses for patients with metabolic dysfunction–associated steatotic liver disease. PLoS ONE. 20(2). e0317929–e0317929. 1 indexed citations
4.
Alghamdi, Saad, Ali Albenmousa, Khalid Bzeizi, et al.. (2023). Diabetes mellitus is not associated with worse short term outcome in patients older than 65 years old post-liver transplantation. World Journal of Hepatology. 15(2). 274–281.
5.
Broering, Dieter, Ali Albenmousa, Faisal Abaalkhail, et al.. (2021). Validating controlled attenuation parameter in the assessment of hepatic steatosis in living liver donors. PLoS ONE. 16(5). e0251487–e0251487. 6 indexed citations
6.
Alqahtani, Saleh A., Dieter Broering, Saad Alghamdi, et al.. (2021). Changing trends in liver transplantation indications in Saudi Arabia: from hepatitis C virus infection to nonalcoholic fatty liver disease. BMC Gastroenterology. 21(1). 245–245. 14 indexed citations
7.
Bzeizi, Khalid, Ali Albenmousa, Ahmed Zidan, et al.. (2021). Efficacy and safety of once daily tacrolimus compared to twice daily tacrolimus after liver transplantation. World Journal of Hepatology. 13(3). 375–383. 3 indexed citations
8.
Al–Hamoudi, Waleed, Hisham Alkhalidi, Ayman A. Abdo, et al.. (2020). Endothelial dysfunction in nonalcoholic steatohepatitis with low cardiac disease risk. Scientific Reports. 10(1). 8825–8825. 9 indexed citations
9.
Aljumah, Abdulrahman, et al.. (2019). Acute onset autoimmune hepatitis: Clinical presentation and treatment outcomes. Annals of Hepatology. 18(3). 439–444. 20 indexed citations
10.
Al‐Anazi, Mashael R., Sabine Matou‐Nasri, Arwa A. Al-Qahtani, et al.. (2019). Association between IL-37 gene polymorphisms and risk of HBV-related liver disease in a Saudi Arabian population. Scientific Reports. 9(1). 7123–7123. 15 indexed citations
11.
Zakaria, Hazem, Ahmed Zidan, Mark Sturdevant, et al.. (2019). Is It Justified to Use Liver Grafts From Living Donors for Retransplant? A Single-Center Experience. Experimental and Clinical Transplantation. 18(2). 188–195. 7 indexed citations
12.
Aljumah, Abdulrahman, et al.. (2018). The Saudi association for the study of liver diseases and transplantation clinical practice guidelines for management of autoimmune hepatitis. Saudi Journal of Gastroenterology. 24(7). 1–1. 6 indexed citations
13.
Al‐Ghamdi, Saleh A., et al.. (2017). Gastropleural fistula after single anastomosis gastric bypass. A case report and review of the literature. International Journal of Surgery Case Reports. 35. 82–86. 18 indexed citations
14.
Aljumah, Abdulrahman, et al.. (2016). Clinical Presentation, Treatment Outcome and Predictors of Severity in Autoimmune Hepatitis: A Retrospective, Multicenter Experience. Journal of Gastroenterology and Hepatology Research. 5(4). 2047–2051. 1 indexed citations
15.
Albenmousa, Ali, et al.. (2016). Primary experience of bariatric surgery in a newly established private obesity center. Saudi Medical Journal. 37(10). 1089–1095. 9 indexed citations
16.
Al‐Qahtani, Ahmed A., Mashael R. Al‐Anazi, Ayman A. Abdo, et al.. (2015). Correlation between Genetic Variations and Serum Level of Interleukin 28B with Virus Genotypes and Disease Progression in Chronic Hepatitis C Virus Infection. Journal of Immunology Research. 2015. 1–10. 23 indexed citations
17.
Al‐Qahtani, Ahmed A., Mashael R. Al‐Anazi, Fahad Al-Zoghaibi, et al.. (2014). The Association of Toll-Like Receptor 4 Polymorphism with Hepatitis C Virus Infection in Saudi Arabian Patients. BioMed Research International. 2014. 1–9. 21 indexed citations
18.
Al‐Anazi, Mashael R., Sabine Matou‐Nasri, Ayman A. Abdo, et al.. (2014). Variations in DEPDC5 gene and its association with chronic hepatitis C virus infection in Saudi Arabia. BMC Infectious Diseases. 14(1). 632–632. 7 indexed citations
19.
Albenmousa, Ali, et al.. (2011). Liver abscess presentation and management in Saudi Arabia and the United Kingdom. Annals of Saudi Medicine. 31(5). 528–532. 8 indexed citations
20.
Sanai, Faisal M., Ali Albenmousa, Abdulmalik Alsheikh, et al.. (2010). Prevalence and Impact of Hepatic Steatosis on the Response to Antiviral Therapy in Saudi Patients with Genotypes 1 and 4 Chronic Hepatitis C. Digestive Diseases and Sciences. 56(4). 1222–1228. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026